270 related articles for article (PubMed ID: 6210909)
1. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus.
Leiter EH
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):630-4. PubMed ID: 6210909
[TBL] [Abstract][Full Text] [Related]
2. Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia.
Sandler S; Andersson A
Diabetes; 1982 Aug; 31 Suppl 4():78-83. PubMed ID: 6219904
[TBL] [Abstract][Full Text] [Related]
3. The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice.
Leiter EH; Beamer WG; Shultz LD
Diabetes; 1983 Feb; 32(2):148-55. PubMed ID: 6219026
[TBL] [Abstract][Full Text] [Related]
4. The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice.
Nakamura M; Nagafuchi S; Yamaguchi K; Takaki R
Diabetes; 1984 Sep; 33(9):894-900. PubMed ID: 6236118
[TBL] [Abstract][Full Text] [Related]
5. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes.
Paik SG; Fleischer N; Shin SI
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6129-33. PubMed ID: 6449703
[TBL] [Abstract][Full Text] [Related]
6. Protection by dimethyl urea against hyperglycaemia, but not insulitis, in low-dose streptozotocin-induced diabetes in the mouse.
Sandler S
Diabetologia; 1984 May; 26(5):386-8. PubMed ID: 6234194
[TBL] [Abstract][Full Text] [Related]
7. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
Herold KC; Baumann E; Vezys V; Buckingham F
J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 promotes hyperglycemia and insulitis in mice normally resistant to streptozotocin-induced diabetes.
Zunino SJ; Simons LF; Sambrook JF; Gething MJ
Am J Pathol; 1994 Sep; 145(3):661-70. PubMed ID: 8080048
[TBL] [Abstract][Full Text] [Related]
9. IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice.
Pavlovic S; Petrovic I; Jovicic N; Ljujic B; Miletic Kovacevic M; Arsenijevic N; Lukic ML
Front Immunol; 2018; 9():2646. PubMed ID: 30498495
[TBL] [Abstract][Full Text] [Related]
10. Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozocin-induced insulitis.
Mendola J; Wright JR; Lacy PE
Diabetes; 1989 Mar; 38(3):379-85. PubMed ID: 2521836
[TBL] [Abstract][Full Text] [Related]
11. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells.
Herold KC; Bloch TN; Vezys V; Sun Q
Diabetes; 1995 Mar; 44(3):354-9. PubMed ID: 7883124
[TBL] [Abstract][Full Text] [Related]
12. Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice.
Holstad M; Sandler S
Autoimmunity; 1993; 15(4):311-4. PubMed ID: 8136460
[TBL] [Abstract][Full Text] [Related]
13. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia.
Rossini AA; Appel MC; Williams RM; Like AA
Diabetes; 1977 Oct; 26(10):916-20. PubMed ID: 143386
[TBL] [Abstract][Full Text] [Related]
14. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens.
Paik SG; Michelis MA; Kim YT; Shin S
Diabetes; 1982 Aug; 31(8 Pt 1):724-9. PubMed ID: 6219020
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic gangliosides delay the onset of insulitis and hyperglycaemia in the low-dose streptozotocin mouse model.
Anastasi E; Tiberti C; Sensi M; Ponte E; Filippetti R; Dotta F; Vecci E; Fiori MG; Di Mario U
Scand J Immunol; 1993 Mar; 37(3):308-13. PubMed ID: 8441917
[TBL] [Abstract][Full Text] [Related]
16. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes.
Flodström M; Tyrberg B; Eizirik DL; Sandler S
Diabetes; 1999 Apr; 48(4):706-13. PubMed ID: 10102685
[TBL] [Abstract][Full Text] [Related]
17. Low dose streptozotocin causes diabetes in severe combined immunodeficient (SCID) mice without immune cell infiltration of the pancreatic islets.
Reddy S; Wu D; Elliott RB
Autoimmunity; 1995; 20(2):83-92. PubMed ID: 7578872
[TBL] [Abstract][Full Text] [Related]
18. Modulation of streptozotocin-induced insulitis and hyperglycaemia in the mouse.
Sandler S; Andersson A
Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):93-8. PubMed ID: 3157292
[TBL] [Abstract][Full Text] [Related]
19. Morphologic-histochemical characterization of inflammatory cells in insulitis induced by multiple subdiabetogenic doses of streptozotocin in C57B1/KsJ mice.
Schneider E; Wohlrab F; Cossel L
Biomed Biochim Acta; 1984; 43(5):683-90. PubMed ID: 6236802
[TBL] [Abstract][Full Text] [Related]
20. Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice.
Li Z; Karlsson FA; Sandler S
J Endocrinol; 2000 Apr; 165(1):93-9. PubMed ID: 10750039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
